Anthem Inc
ANTM
Market Cap$114.59B
Close$
Earnings Call Q2 2024
July 17, 2024 - AI Summary
Elevance Health reported second quarter adjusted diluted earnings per share of $10.12, representing 12% growth year-over-year.
The company reaffirmed its full-year adjusted diluted earnings per share guidance of at least $37.20, reflecting 12% growth year-over-year.
In the Commercial Health Benefits business, Elevance Health saw solid membership growth, particularly in the individual ACA business, which has grown substantially year-over-year.
Exclusive for Stockcircle Pro members
Sign up
$501.77
4% upside
Current Fair Value
4% upsideUndervalued by 4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $114.59 Billion |
|---|---|
| Enterprise Value | $137.26 Billion |
| Dividend Yield | $29.003 (1.29453126587681%) |
| Earnings per Share | $25.38 |
| Beta | 0.97 |
| Outstanding Shares | 232,200,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 34.38 |
|---|---|
| PEG | 142.52 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 2.65 |
| Enterprise Value to Revenue | 0.8 |
| Enterprise Value to EBIT | 1.99 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.69 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Anthem Inc
CEO: Gail Boudreaux